

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H2A acetylation (GO:0043968) | 8.65369535 |
| 2 | phosphate ion transport (GO:0006817) | 7.26998046 |
| 3 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 5.48191419 |
| 4 | urate metabolic process (GO:0046415) | 5.44488479 |
| 5 | phosphate ion transmembrane transport (GO:0035435) | 5.13478747 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.55585013 |
| 7 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.02545128 |
| 8 | negative regulation of heart rate (GO:0010459) | 4.02073847 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97341132 |
| 10 | tachykinin receptor signaling pathway (GO:0007217) | 3.90970729 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84889620 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.84889620 |
| 13 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.82058131 |
| 14 | presynaptic membrane organization (GO:0097090) | 3.70451152 |
| 15 | peristalsis (GO:0030432) | 3.65475940 |
| 16 | iron-sulfur cluster assembly (GO:0016226) | 3.61378617 |
| 17 | metallo-sulfur cluster assembly (GO:0031163) | 3.61378617 |
| 18 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.61078668 |
| 19 | presynaptic membrane assembly (GO:0097105) | 3.59042023 |
| 20 | DNA unwinding involved in DNA replication (GO:0006268) | 3.55785109 |
| 21 | proline transport (GO:0015824) | 3.55621659 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54762790 |
| 23 | purine-containing compound salvage (GO:0043101) | 3.53541287 |
| 24 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.52975701 |
| 25 | purine nucleobase biosynthetic process (GO:0009113) | 3.51648403 |
| 26 | transmission of nerve impulse (GO:0019226) | 3.51068889 |
| 27 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.46419197 |
| 28 | peroxisome fission (GO:0016559) | 3.46409869 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43730056 |
| 30 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.43477449 |
| 31 | fatty acid elongation (GO:0030497) | 3.43369196 |
| 32 | L-methionine salvage (GO:0071267) | 3.42866861 |
| 33 | L-methionine biosynthetic process (GO:0071265) | 3.42866861 |
| 34 | amino acid salvage (GO:0043102) | 3.42866861 |
| 35 | ribosomal small subunit assembly (GO:0000028) | 3.39457692 |
| 36 | magnesium ion transport (GO:0015693) | 3.39120803 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 3.34849844 |
| 38 | regulation of hippo signaling (GO:0035330) | 3.31778970 |
| 39 | hyperosmotic salinity response (GO:0042538) | 3.30467545 |
| 40 | photoreceptor cell maintenance (GO:0045494) | 3.29720054 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21420352 |
| 42 | regulation of RNA export from nucleus (GO:0046831) | 3.17662915 |
| 43 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.17344326 |
| 44 | histone H4-K12 acetylation (GO:0043983) | 3.17261387 |
| 45 | DNA strand elongation (GO:0022616) | 3.16249552 |
| 46 | nucleobase biosynthetic process (GO:0046112) | 3.15785961 |
| 47 | signal peptide processing (GO:0006465) | 3.15376948 |
| 48 | Golgi transport vesicle coating (GO:0048200) | 3.13224208 |
| 49 | COPI coating of Golgi vesicle (GO:0048205) | 3.13224208 |
| 50 | DNA double-strand break processing (GO:0000729) | 3.12500321 |
| 51 | oxaloacetate metabolic process (GO:0006107) | 3.06740570 |
| 52 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.05605558 |
| 53 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.05605558 |
| 54 | nuclear pore complex assembly (GO:0051292) | 3.05386692 |
| 55 | folic acid metabolic process (GO:0046655) | 3.04714915 |
| 56 | energy homeostasis (GO:0097009) | 3.03933310 |
| 57 | protein deneddylation (GO:0000338) | 3.03880432 |
| 58 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.02979994 |
| 59 | protein localization to cilium (GO:0061512) | 3.00412482 |
| 60 | glycoside metabolic process (GO:0016137) | 2.99842662 |
| 61 | trivalent inorganic anion homeostasis (GO:0072506) | 2.99001831 |
| 62 | phosphate ion homeostasis (GO:0055062) | 2.99001831 |
| 63 | response to parathyroid hormone (GO:0071107) | 2.98314494 |
| 64 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.96666203 |
| 65 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96298882 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.95732353 |
| 67 | negative regulation of dendrite development (GO:2000171) | 2.95165842 |
| 68 | glycoprotein catabolic process (GO:0006516) | 2.94701993 |
| 69 | defense response to protozoan (GO:0042832) | 2.94378071 |
| 70 | positive regulation of mitochondrial fission (GO:0090141) | 2.94164620 |
| 71 | intraciliary transport (GO:0042073) | 2.91764140 |
| 72 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.89259117 |
| 73 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.88545702 |
| 74 | NADH dehydrogenase complex assembly (GO:0010257) | 2.88545702 |
| 75 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.88545702 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.86829109 |
| 77 | detection of calcium ion (GO:0005513) | 2.84180071 |
| 78 | tricarboxylic acid metabolic process (GO:0072350) | 2.83169017 |
| 79 | epoxygenase P450 pathway (GO:0019373) | 2.82656312 |
| 80 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.82644599 |
| 81 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.80973170 |
| 82 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.80973170 |
| 83 | photoreceptor cell development (GO:0042461) | 2.80874475 |
| 84 | response to mercury ion (GO:0046689) | 2.80438780 |
| 85 | response to lead ion (GO:0010288) | 2.80243901 |
| 86 | snRNA transcription (GO:0009301) | 2.79755520 |
| 87 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.79282418 |
| 88 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.78731784 |
| 89 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.78731784 |
| 90 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.78731784 |
| 91 | negative regulation of DNA recombination (GO:0045910) | 2.77636408 |
| 92 | negative regulation of protein localization to cell surface (GO:2000009) | 2.76525837 |
| 93 | response to protozoan (GO:0001562) | 2.76332395 |
| 94 | C4-dicarboxylate transport (GO:0015740) | 2.75871155 |
| 95 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.75734143 |
| 96 | regulation of dopamine metabolic process (GO:0042053) | 2.75103649 |
| 97 | regulation of catecholamine metabolic process (GO:0042069) | 2.75103649 |
| 98 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.74497688 |
| 99 | NADH metabolic process (GO:0006734) | 2.72735601 |
| 100 | cellular metabolic compound salvage (GO:0043094) | 2.72528089 |
| 101 | negative regulation of cell killing (GO:0031342) | 2.70138416 |
| 102 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70138416 |
| 103 | negative regulation of neurological system process (GO:0031645) | 2.68964659 |
| 104 | cullin deneddylation (GO:0010388) | 2.67855286 |
| 105 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.67838791 |
| 106 | cellular ketone body metabolic process (GO:0046950) | 2.67287915 |
| 107 | chaperone-mediated protein transport (GO:0072321) | 2.65992053 |
| 108 | tricarboxylic acid cycle (GO:0006099) | 2.65718274 |
| 109 | prenylation (GO:0097354) | 2.65453365 |
| 110 | protein prenylation (GO:0018342) | 2.65453365 |
| 111 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64678912 |
| 112 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.63481542 |
| 113 | positive regulation of heart rate (GO:0010460) | 2.63464471 |
| 114 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.63361767 |
| 115 | methionine biosynthetic process (GO:0009086) | 2.63268970 |
| 116 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.59991909 |
| 117 | striatum development (GO:0021756) | 2.59644984 |
| 118 | histone mRNA metabolic process (GO:0008334) | 2.58341827 |
| 119 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.57392940 |
| 120 | daunorubicin metabolic process (GO:0044597) | 2.57102672 |
| 121 | polyketide metabolic process (GO:0030638) | 2.57102672 |
| 122 | doxorubicin metabolic process (GO:0044598) | 2.57102672 |
| 123 | positive regulation of action potential (GO:0045760) | 2.56640734 |
| 124 | histone exchange (GO:0043486) | 2.56079285 |
| 125 | DNA deamination (GO:0045006) | 2.54972736 |
| 126 | lysine catabolic process (GO:0006554) | 2.54580650 |
| 127 | lysine metabolic process (GO:0006553) | 2.54580650 |
| 128 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54244535 |
| 129 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.53555649 |
| 130 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.53555649 |
| 131 | response to pheromone (GO:0019236) | 2.53377635 |
| 132 | methionine metabolic process (GO:0006555) | 2.53058160 |
| 133 | indole-containing compound metabolic process (GO:0042430) | 2.52868501 |
| 134 | negative T cell selection (GO:0043383) | 2.52777557 |
| 135 | serine family amino acid biosynthetic process (GO:0009070) | 2.52553256 |
| 136 | mitotic G2/M transition checkpoint (GO:0044818) | 2.52203047 |
| 137 | nuclear pore organization (GO:0006999) | 2.51852103 |
| 138 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.51245321 |
| 139 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50169212 |
| 140 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.49791329 |
| 141 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.48863665 |
| 142 | coenzyme A metabolic process (GO:0015936) | 2.48337171 |
| 143 | telomere maintenance via recombination (GO:0000722) | 2.47546312 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.47356346 |
| 145 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.46655673 |
| 146 | glycine metabolic process (GO:0006544) | 2.46567532 |
| 147 | intra-S DNA damage checkpoint (GO:0031573) | 2.46557370 |
| 148 | cellular response to ammonium ion (GO:0071242) | 2.46545029 |
| 149 | regulation of helicase activity (GO:0051095) | 2.45645130 |
| 150 | sulfur amino acid biosynthetic process (GO:0000097) | 2.45143016 |
| 151 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.45129523 |
| 152 | L-phenylalanine catabolic process (GO:0006559) | 2.45129523 |
| 153 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.44954069 |
| 154 | valine metabolic process (GO:0006573) | 2.44912615 |
| 155 | eye photoreceptor cell development (GO:0042462) | 2.42839614 |
| 156 | histone H4 acetylation (GO:0043967) | 2.42186137 |
| 157 | synapsis (GO:0007129) | 2.41909849 |
| 158 | necroptotic process (GO:0070266) | 2.41758926 |
| 159 | replication fork processing (GO:0031297) | 2.41341888 |
| 160 | negative regulation of DNA repair (GO:0045738) | 2.40987923 |
| 161 | parental behavior (GO:0060746) | 2.40775047 |
| 162 | short-chain fatty acid metabolic process (GO:0046459) | 2.40719291 |
| 163 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.40216183 |
| 164 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.40216183 |
| 165 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.40216183 |
| 166 | reflex (GO:0060004) | 2.39746287 |
| 167 | CENP-A containing nucleosome assembly (GO:0034080) | 2.39682998 |
| 168 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.38760339 |
| 169 | negative thymic T cell selection (GO:0045060) | 2.38719072 |
| 170 | chromatin remodeling at centromere (GO:0031055) | 2.38647844 |
| 171 | regulation of B cell differentiation (GO:0045577) | 2.38574562 |
| 172 | purine nucleobase metabolic process (GO:0006144) | 2.38070969 |
| 173 | nucleoside salvage (GO:0043174) | 2.38016382 |
| 174 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.37897651 |
| 175 | detection of light stimulus involved in visual perception (GO:0050908) | 2.37897651 |
| 176 | IMP metabolic process (GO:0046040) | 2.37347585 |
| 177 | acyl-CoA biosynthetic process (GO:0071616) | 2.37210207 |
| 178 | thioester biosynthetic process (GO:0035384) | 2.37210207 |
| 179 | succinate metabolic process (GO:0006105) | 2.37044039 |
| 180 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.36082057 |
| 181 | L-fucose catabolic process (GO:0042355) | 2.35769665 |
| 182 | fucose catabolic process (GO:0019317) | 2.35769665 |
| 183 | L-fucose metabolic process (GO:0042354) | 2.35769665 |
| 184 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.35617604 |
| 185 | behavioral response to nicotine (GO:0035095) | 2.35312970 |
| 186 | regulation of pigment cell differentiation (GO:0050932) | 2.35310287 |
| 187 | regulation of relaxation of muscle (GO:1901077) | 2.34689274 |
| 188 | behavioral response to ethanol (GO:0048149) | 2.34434753 |
| 189 | adult heart development (GO:0007512) | 2.33914358 |
| 190 | DNA replication initiation (GO:0006270) | 2.33531223 |
| 191 | telomere organization (GO:0032200) | 2.33103554 |
| 192 | cilium morphogenesis (GO:0060271) | 2.33033099 |
| 193 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.32497604 |
| 194 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.32038806 |
| 195 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.31652545 |
| 196 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.31365353 |
| 197 | neuronal action potential (GO:0019228) | 2.31263690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.53799247 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.33486288 |
| 3 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.25835902 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25371099 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.12642509 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.98589173 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.97223685 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.92545547 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.89243640 |
| 10 | FUS_26573619_Chip-Seq_HEK293_Human | 2.85990114 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.77175150 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.75674206 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.68802604 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.67249870 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.67079740 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.61541452 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.52500655 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.51511327 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49984717 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49641064 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.44244172 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.41662534 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.35807354 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.35581530 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.29557949 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23352318 |
| 27 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.21563173 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21065055 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.20457193 |
| 30 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.15136367 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14422103 |
| 32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.14242787 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14172761 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.12953634 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10703192 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 2.09839873 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06981571 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06299374 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06156300 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04679358 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04575548 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.02698659 |
| 43 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.01966172 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00442052 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99578637 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97804217 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.97650913 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96485325 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96280177 |
| 50 | EWS_26573619_Chip-Seq_HEK293_Human | 1.95831583 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.95417277 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90435407 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.90328070 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.90174983 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.89607015 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.87965087 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.87266359 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.87065920 |
| 59 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.85292719 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.79760908 |
| 61 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78144837 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.77198806 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72811823 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.72749417 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72729620 |
| 66 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71798531 |
| 67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.69955296 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67890973 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67798359 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.65749111 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65165861 |
| 72 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64851895 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.64778214 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.64093828 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63807520 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63595100 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63092121 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61977327 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.61308339 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59939834 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59346697 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.59166438 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.58272951 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.58067555 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56978187 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55389877 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52708325 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50891604 |
| 89 | MYB_26560356_Chip-Seq_TH2_Human | 1.50860396 |
| 90 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.50779129 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49759222 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49746482 |
| 93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49596310 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.49433692 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 1.49210429 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47585746 |
| 97 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46884399 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46311108 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44458378 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44065736 |
| 101 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.43596794 |
| 102 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43117196 |
| 103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.42196931 |
| 104 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41154382 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41032203 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40965616 |
| 107 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40694585 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.40463320 |
| 109 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40369360 |
| 110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38161601 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37027088 |
| 112 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36907287 |
| 113 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.36324625 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.36148385 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35825222 |
| 116 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.34886358 |
| 117 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.34210455 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.32674820 |
| 119 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32192652 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31491088 |
| 121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29662268 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28748299 |
| 123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26955770 |
| 124 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26579039 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25295584 |
| 126 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25054909 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24619384 |
| 128 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23773980 |
| 129 | MYB_26560356_Chip-Seq_TH1_Human | 1.23148056 |
| 130 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23125527 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22702724 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.22070011 |
| 133 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21184051 |
| 134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21134173 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20782599 |
| 136 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19926965 |
| 137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19102442 |
| 138 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18589240 |
| 139 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17625717 |
| 140 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16962001 |
| 141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16733884 |
| 142 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14951673 |
| 143 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.14830851 |
| 144 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14812381 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14748053 |
| 146 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14331837 |
| 147 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13368249 |
| 148 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13368249 |
| 149 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12946471 |
| 150 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12198694 |
| 151 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11991895 |
| 152 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11868131 |
| 153 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11746597 |
| 154 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10930861 |
| 155 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10377781 |
| 156 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10111031 |
| 157 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10092320 |
| 158 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09802998 |
| 159 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09140456 |
| 160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08458308 |
| 161 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07646406 |
| 162 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07289877 |
| 163 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.07091212 |
| 164 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06561669 |
| 165 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05370389 |
| 166 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.05149695 |
| 167 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05142134 |
| 168 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04399226 |
| 169 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04036933 |
| 170 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03598025 |
| 171 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03598025 |
| 172 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02091903 |
| 173 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01612071 |
| 174 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01273034 |
| 175 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01120358 |
| 176 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00245455 |
| 177 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00231827 |
| 178 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00186584 |
| 179 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98365825 |
| 180 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98279645 |
| 181 | MAF_26560356_Chip-Seq_TH1_Human | 0.97896080 |
| 182 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97877000 |
| 183 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.97538469 |
| 184 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.97345482 |
| 185 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96595339 |
| 186 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96226152 |
| 187 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95818479 |
| 188 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95572680 |
| 189 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95392303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.65605632 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.27712278 |
| 3 | MP0005671_abnormal_response_to | 3.22423531 |
| 4 | MP0003880_abnormal_central_pattern | 3.15946252 |
| 5 | MP0003890_abnormal_embryonic-extraembry | 2.94488404 |
| 6 | MP0001984_abnormal_olfaction | 2.82572376 |
| 7 | MP0005365_abnormal_bile_salt | 2.80948416 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.56497062 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.55932356 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.55163190 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.54978820 |
| 12 | MP0005360_urolithiasis | 2.48359468 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.44408456 |
| 14 | MP0001485_abnormal_pinna_reflex | 2.34525730 |
| 15 | MP0000427_abnormal_hair_cycle | 2.28329144 |
| 16 | MP0002822_catalepsy | 2.28274428 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 2.23012045 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.13709797 |
| 19 | MP0001873_stomach_inflammation | 2.12676280 |
| 20 | MP0001486_abnormal_startle_reflex | 2.09308114 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.06953060 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 2.05760911 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.02469691 |
| 24 | MP0002398_abnormal_bone_marrow | 2.01340019 |
| 25 | MP0001800_abnormal_humoral_immune | 2.00650746 |
| 26 | MP0010094_abnormal_chromosome_stability | 1.99880467 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.99555172 |
| 28 | MP0005083_abnormal_biliary_tract | 1.97828874 |
| 29 | MP0002102_abnormal_ear_morphology | 1.96504518 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95815595 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.92355007 |
| 32 | MP0000685_abnormal_immune_system | 1.91519972 |
| 33 | MP0009785_altered_susceptibility_to | 1.90094304 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.89294425 |
| 35 | MP0000516_abnormal_urinary_system | 1.86513567 |
| 36 | MP0005367_renal/urinary_system_phenotyp | 1.86513567 |
| 37 | MP0001529_abnormal_vocalization | 1.86253586 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.83207595 |
| 39 | MP0003878_abnormal_ear_physiology | 1.83207595 |
| 40 | MP0006054_spinal_hemorrhage | 1.83080336 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.83075258 |
| 42 | MP0004147_increased_porphyrin_level | 1.80756909 |
| 43 | MP0005253_abnormal_eye_physiology | 1.79815362 |
| 44 | MP0002723_abnormal_immune_serum | 1.79358534 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.78978599 |
| 46 | MP0001819_abnormal_immune_cell | 1.75530254 |
| 47 | MP0003186_abnormal_redox_activity | 1.75294621 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.74443107 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.71661729 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.71647363 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.69320891 |
| 52 | MP0000716_abnormal_immune_system | 1.65165313 |
| 53 | MP0003941_abnormal_skin_development | 1.64696004 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.62387623 |
| 55 | MP0003077_abnormal_cell_cycle | 1.61530428 |
| 56 | MP0002722_abnormal_immune_system | 1.61479187 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.59082190 |
| 58 | MP0002132_abnormal_respiratory_system | 1.58332766 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.56160287 |
| 60 | MP0009046_muscle_twitch | 1.55837210 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.55385535 |
| 62 | MP0002429_abnormal_blood_cell | 1.54647961 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.52401885 |
| 64 | MP0008057_abnormal_DNA_replication | 1.52111323 |
| 65 | MP0005025_abnormal_response_to | 1.50644255 |
| 66 | MP0006082_CNS_inflammation | 1.50066668 |
| 67 | MP0008775_abnormal_heart_ventricle | 1.47119136 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.46212759 |
| 69 | MP0004085_abnormal_heartbeat | 1.45514114 |
| 70 | MP0009697_abnormal_copulation | 1.44996338 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.44600972 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.44261610 |
| 73 | MP0000490_abnormal_crypts_of | 1.42170777 |
| 74 | MP0010386_abnormal_urinary_bladder | 1.39226627 |
| 75 | MP0003866_abnormal_defecation | 1.39091892 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.38057492 |
| 77 | MP0003436_decreased_susceptibility_to | 1.37181924 |
| 78 | MP0005310_abnormal_salivary_gland | 1.36932337 |
| 79 | MP0004510_myositis | 1.36158191 |
| 80 | MP0003137_abnormal_impulse_conducting | 1.35156132 |
| 81 | MP0000383_abnormal_hair_follicle | 1.32784077 |
| 82 | MP0004484_altered_response_of | 1.31021758 |
| 83 | MP0003787_abnormal_imprinting | 1.30751803 |
| 84 | MP0000609_abnormal_liver_physiology | 1.29295728 |
| 85 | MP0002638_abnormal_pupillary_reflex | 1.28896698 |
| 86 | MP0002735_abnormal_chemical_nociception | 1.27942116 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.27869473 |
| 88 | MP0002419_abnormal_innate_immunity | 1.27827860 |
| 89 | MP0001764_abnormal_homeostasis | 1.27681701 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 1.27184922 |
| 91 | MP0002160_abnormal_reproductive_system | 1.26181811 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 1.25480623 |
| 93 | MP0009745_abnormal_behavioral_response | 1.24580643 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 1.24469797 |
| 95 | MP0000749_muscle_degeneration | 1.23778411 |
| 96 | MP0000604_amyloidosis | 1.23224001 |
| 97 | MP0001666_abnormal_nutrient_absorption | 1.22763860 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 1.22413155 |
| 99 | MP0004947_skin_inflammation | 1.21938561 |
| 100 | MP0001845_abnormal_inflammatory_respons | 1.21809143 |
| 101 | MP0003635_abnormal_synaptic_transmissio | 1.21089281 |
| 102 | MP0002006_tumorigenesis | 1.20122303 |
| 103 | MP0001790_abnormal_immune_system | 1.19967166 |
| 104 | MP0005387_immune_system_phenotype | 1.19967166 |
| 105 | MP0009672_abnormal_birth_weight | 1.19733565 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19180622 |
| 107 | MP0008058_abnormal_DNA_repair | 1.19079766 |
| 108 | MP0009840_abnormal_foam_cell | 1.18031800 |
| 109 | MP0002272_abnormal_nervous_system | 1.17250969 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 1.16392327 |
| 111 | MP0003123_paternal_imprinting | 1.14403404 |
| 112 | MP0000778_abnormal_nervous_system | 1.12513224 |
| 113 | MP0008469_abnormal_protein_level | 1.12047525 |
| 114 | MP0003724_increased_susceptibility_to | 1.11872700 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 1.11018761 |
| 116 | MP0010329_abnormal_lipoprotein_level | 1.10909781 |
| 117 | MP0003252_abnormal_bile_duct | 1.10296558 |
| 118 | MP0002734_abnormal_mechanical_nocicepti | 1.10183067 |
| 119 | MP0002063_abnormal_learning/memory/cond | 1.09839506 |
| 120 | MP0003136_yellow_coat_color | 1.09732688 |
| 121 | MP0005332_abnormal_amino_acid | 1.09582638 |
| 122 | MP0000569_abnormal_digit_pigmentation | 1.09386952 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 1.09214746 |
| 124 | MP0002019_abnormal_tumor_incidence | 1.08927210 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 1.08570524 |
| 126 | MP0002405_respiratory_system_inflammati | 1.08350718 |
| 127 | MP0005248_abnormal_Harderian_gland | 1.07662915 |
| 128 | MP0001545_abnormal_hematopoietic_system | 1.07226330 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 1.07226330 |
| 130 | MP0009643_abnormal_urine_homeostasis | 1.05783957 |
| 131 | MP0003172_abnormal_lysosome_physiology | 1.04277730 |
| 132 | MP0002148_abnormal_hypersensitivity_rea | 1.04276880 |
| 133 | MP0002067_abnormal_sensory_capabilities | 1.03745970 |
| 134 | MP0005195_abnormal_posterior_eye | 1.03390896 |
| 135 | MP0002138_abnormal_hepatobiliary_system | 1.03220555 |
| 136 | MP0003329_amyloid_beta_deposits | 1.01452031 |
| 137 | MP0004924_abnormal_behavior | 1.01177984 |
| 138 | MP0005386_behavior/neurological_phenoty | 1.01177984 |
| 139 | MP0005266_abnormal_metabolism | 1.00335213 |
| 140 | MP0001177_atelectasis | 1.00074210 |
| 141 | MP0000598_abnormal_liver_morphology | 0.99809143 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.99611983 |
| 143 | MP0002751_abnormal_autonomic_nervous | 0.98990113 |
| 144 | MP0003191_abnormal_cellular_cholesterol | 0.98692347 |
| 145 | MP0005499_abnormal_olfactory_system | 0.98601427 |
| 146 | MP0005394_taste/olfaction_phenotype | 0.98601427 |
| 147 | MP0001293_anophthalmia | 0.98249457 |
| 148 | MP0002184_abnormal_innervation | 0.96500246 |
| 149 | MP0002064_seizures | 0.96187825 |
| 150 | MP0000538_abnormal_urinary_bladder | 0.96122774 |
| 151 | MP0001853_heart_inflammation | 0.95337891 |
| 152 | MP0004270_analgesia | 0.94581841 |
| 153 | MP0005319_abnormal_enzyme/_coenzyme | 0.94018429 |
| 154 | MP0005058_abnormal_lysosome_morphology | 0.93780038 |
| 155 | MP0002752_abnormal_somatic_nervous | 0.92729973 |
| 156 | MP0002095_abnormal_skin_pigmentation | 0.92261738 |
| 157 | MP0002572_abnormal_emotion/affect_behav | 0.91053713 |
| 158 | MP0004133_heterotaxia | 0.90888478 |
| 159 | MP0001730_embryonic_growth_arrest | 0.89532849 |
| 160 | MP0001663_abnormal_digestive_system | 0.89266416 |
| 161 | MP0006035_abnormal_mitochondrial_morpho | 0.86702097 |
| 162 | MP0002933_joint_inflammation | 0.85654292 |
| 163 | MP0002229_neurodegeneration | 0.85503849 |
| 164 | MP0000372_irregular_coat_pigmentation | 0.85371620 |
| 165 | MP0000350_abnormal_cell_proliferation | 0.85287273 |
| 166 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85275155 |
| 167 | MP0005187_abnormal_penis_morphology | 0.84286306 |
| 168 | MP0002733_abnormal_thermal_nociception | 0.82380848 |
| 169 | MP0003111_abnormal_nucleus_morphology | 0.82352222 |
| 170 | MP0003195_calcinosis | 0.82025256 |
| 171 | MP0008789_abnormal_olfactory_epithelium | 0.79624910 |
| 172 | MP0010352_gastrointestinal_tract_polyps | 0.78528846 |
| 173 | MP0002090_abnormal_vision | 0.78374678 |
| 174 | MP0009703_decreased_birth_body | 0.77275834 |
| 175 | MP0002069_abnormal_eating/drinking_beha | 0.74661408 |
| 176 | MP0001963_abnormal_hearing_physiology | 0.74617552 |
| 177 | MP0005389_reproductive_system_phenotype | 0.74497682 |
| 178 | MP0000647_abnormal_sebaceous_gland | 0.73278086 |
| 179 | MP0002928_abnormal_bile_duct | 0.73249235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubulopathy (HP:0000114) | 5.80472627 |
| 2 | Renal cortical cysts (HP:0000803) | 4.20502007 |
| 3 | IgM deficiency (HP:0002850) | 4.08929280 |
| 4 | Thrombocytosis (HP:0001894) | 3.78722269 |
| 5 | Hypoplasia of the thymus (HP:0000778) | 3.71981360 |
| 6 | Increased serum pyruvate (HP:0003542) | 3.55486175 |
| 7 | Abnormality of glycolysis (HP:0004366) | 3.55486175 |
| 8 | Pendular nystagmus (HP:0012043) | 3.53456101 |
| 9 | True hermaphroditism (HP:0010459) | 3.51345337 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.49749706 |
| 11 | T lymphocytopenia (HP:0005403) | 3.43346264 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.38742179 |
| 13 | Pancreatic cysts (HP:0001737) | 3.30054617 |
| 14 | Abnormality of B cell number (HP:0010975) | 3.29636180 |
| 15 | B lymphocytopenia (HP:0010976) | 3.29636180 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.27266407 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.26267752 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.17408285 |
| 19 | Glycosuria (HP:0003076) | 2.99222234 |
| 20 | Abnormality of urine glucose concentration (HP:0011016) | 2.99222234 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 2.95424641 |
| 22 | Chronic otitis media (HP:0000389) | 2.94528215 |
| 23 | Fatigue (HP:0012378) | 2.93885220 |
| 24 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.93508059 |
| 25 | Abnormality of vitamin B metabolism (HP:0004340) | 2.91558741 |
| 26 | Severe visual impairment (HP:0001141) | 2.91180268 |
| 27 | Thyroiditis (HP:0100646) | 2.90360476 |
| 28 | Myokymia (HP:0002411) | 2.83220555 |
| 29 | Combined immunodeficiency (HP:0005387) | 2.81868675 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.81135368 |
| 31 | Abnormality of T cells (HP:0002843) | 2.73742702 |
| 32 | Hepatic necrosis (HP:0002605) | 2.71647622 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.71613020 |
| 34 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.71613020 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69966041 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.67302977 |
| 37 | Congenital primary aphakia (HP:0007707) | 2.66956303 |
| 38 | Gait imbalance (HP:0002141) | 2.66718607 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 2.66637017 |
| 40 | Congenital stationary night blindness (HP:0007642) | 2.65900873 |
| 41 | Hepatocellular necrosis (HP:0001404) | 2.65185724 |
| 42 | Birth length less than 3rd percentile (HP:0003561) | 2.61656171 |
| 43 | IgG deficiency (HP:0004315) | 2.57498304 |
| 44 | Genital tract atresia (HP:0001827) | 2.55022330 |
| 45 | Abnormality of the renal cortex (HP:0011035) | 2.55005164 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 2.54486887 |
| 47 | Popliteal pterygium (HP:0009756) | 2.53604975 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50772576 |
| 49 | Vaginal atresia (HP:0000148) | 2.47820896 |
| 50 | Pustule (HP:0200039) | 2.47422563 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.47077285 |
| 52 | Pheochromocytoma (HP:0002666) | 2.46698970 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45869078 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.45638749 |
| 55 | Abnormality of macular pigmentation (HP:0008002) | 2.43234848 |
| 56 | Agnosia (HP:0010524) | 2.41786277 |
| 57 | Cystic hygroma (HP:0000476) | 2.40129774 |
| 58 | Abnormality of the pons (HP:0007361) | 2.39453204 |
| 59 | Hyperkalemia (HP:0002153) | 2.39373516 |
| 60 | Postnatal microcephaly (HP:0005484) | 2.39247458 |
| 61 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37517822 |
| 62 | Ketosis (HP:0001946) | 2.36800408 |
| 63 | Abnormality of chromosome stability (HP:0003220) | 2.36029684 |
| 64 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.34486603 |
| 65 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.32607010 |
| 66 | Cellular immunodeficiency (HP:0005374) | 2.31378493 |
| 67 | Poor head control (HP:0002421) | 2.31166675 |
| 68 | Petechiae (HP:0000967) | 2.29207499 |
| 69 | Acanthocytosis (HP:0001927) | 2.27526686 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.25944886 |
| 71 | Postaxial foot polydactyly (HP:0001830) | 2.25466333 |
| 72 | Abnormal number of erythroid precursors (HP:0012131) | 2.24658871 |
| 73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.21420816 |
| 74 | Fair hair (HP:0002286) | 2.19737815 |
| 75 | Lymphoma (HP:0002665) | 2.19102962 |
| 76 | Acute lymphatic leukemia (HP:0006721) | 2.18784037 |
| 77 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.17856180 |
| 78 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.17856180 |
| 79 | Conjugated hyperbilirubinemia (HP:0002908) | 2.17276373 |
| 80 | Optic nerve hypoplasia (HP:0000609) | 2.16532865 |
| 81 | Cerebral edema (HP:0002181) | 2.15528483 |
| 82 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.14936353 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.13867706 |
| 84 | Progressive inability to walk (HP:0002505) | 2.13115635 |
| 85 | Hyperphosphaturia (HP:0003109) | 2.12783642 |
| 86 | Recurrent viral infections (HP:0004429) | 2.12538590 |
| 87 | Rough bone trabeculation (HP:0100670) | 2.12456794 |
| 88 | Hypoplasia of the pons (HP:0012110) | 2.12023991 |
| 89 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.11759601 |
| 90 | Bronchitis (HP:0012387) | 2.11708575 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.11248196 |
| 92 | Lactic acidosis (HP:0003128) | 2.09857072 |
| 93 | Reticulocytopenia (HP:0001896) | 2.09631975 |
| 94 | Abnormality of the labia minora (HP:0012880) | 2.08144279 |
| 95 | IgA deficiency (HP:0002720) | 2.06081182 |
| 96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06074060 |
| 97 | Dyschromatopsia (HP:0007641) | 2.05989459 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.03951205 |
| 99 | Lymphopenia (HP:0001888) | 2.03508533 |
| 100 | Aplastic anemia (HP:0001915) | 2.03309920 |
| 101 | Gout (HP:0001997) | 2.03190656 |
| 102 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.03004817 |
| 103 | Gonadotropin excess (HP:0000837) | 2.02894134 |
| 104 | Generalized aminoaciduria (HP:0002909) | 2.02011142 |
| 105 | Chronic hepatic failure (HP:0100626) | 2.01621430 |
| 106 | Abnormality of homocysteine metabolism (HP:0010919) | 2.00822998 |
| 107 | Homocystinuria (HP:0002156) | 2.00822998 |
| 108 | Cystic liver disease (HP:0006706) | 2.00754778 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 2.00500302 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00500302 |
| 111 | Intestinal atresia (HP:0011100) | 2.00348319 |
| 112 | Focal seizures (HP:0007359) | 2.00044651 |
| 113 | Abnormal protein glycosylation (HP:0012346) | 1.99789160 |
| 114 | Abnormal glycosylation (HP:0012345) | 1.99789160 |
| 115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.99789160 |
| 116 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.99789160 |
| 117 | Mitochondrial inheritance (HP:0001427) | 1.99194577 |
| 118 | Cerebral hypomyelination (HP:0006808) | 1.98487708 |
| 119 | Abnormality of the intrinsic pathway (HP:0010989) | 1.98398586 |
| 120 | Thyroid carcinoma (HP:0002890) | 1.98120857 |
| 121 | 3-Methylglutaconic aciduria (HP:0003535) | 1.97707183 |
| 122 | Furrowed tongue (HP:0000221) | 1.97702821 |
| 123 | Abnormality of the corticospinal tract (HP:0002492) | 1.96962290 |
| 124 | Hypoglycemic coma (HP:0001325) | 1.95910812 |
| 125 | Acute necrotizing encephalopathy (HP:0006965) | 1.95817786 |
| 126 | Epiphyseal stippling (HP:0010655) | 1.95524043 |
| 127 | Poor coordination (HP:0002370) | 1.95274881 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95267321 |
| 129 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93190465 |
| 130 | Prolonged partial thromboplastin time (HP:0003645) | 1.93137587 |
| 131 | Abnormal biliary tract physiology (HP:0012439) | 1.93068728 |
| 132 | Bile duct proliferation (HP:0001408) | 1.93068728 |
| 133 | Abnormal auditory evoked potentials (HP:0006958) | 1.92713704 |
| 134 | Genetic anticipation (HP:0003743) | 1.92568924 |
| 135 | Neurodegeneration (HP:0002180) | 1.91789072 |
| 136 | Abnormality of vitamin metabolism (HP:0100508) | 1.91780529 |
| 137 | Methylmalonic acidemia (HP:0002912) | 1.90706842 |
| 138 | Increased CSF lactate (HP:0002490) | 1.90517713 |
| 139 | Specific learning disability (HP:0001328) | 1.90301724 |
| 140 | Gastrointestinal stroma tumor (HP:0100723) | 1.89998484 |
| 141 | Neutropenia (HP:0001875) | 1.89764374 |
| 142 | Amniotic constriction ring (HP:0009775) | 1.89653548 |
| 143 | Abnormality of placental membranes (HP:0011409) | 1.89653548 |
| 144 | Fat malabsorption (HP:0002630) | 1.89362241 |
| 145 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.89231875 |
| 146 | Progressive cerebellar ataxia (HP:0002073) | 1.89161711 |
| 147 | Ketoacidosis (HP:0001993) | 1.88794139 |
| 148 | Fetal akinesia sequence (HP:0001989) | 1.88599643 |
| 149 | Long clavicles (HP:0000890) | 1.88527438 |
| 150 | Neoplasm of the adrenal gland (HP:0100631) | 1.88406522 |
| 151 | Cerebral hemorrhage (HP:0001342) | 1.87509045 |
| 152 | Attenuation of retinal blood vessels (HP:0007843) | 1.87029804 |
| 153 | Focal motor seizures (HP:0011153) | 1.85501354 |
| 154 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85484389 |
| 155 | Diastasis recti (HP:0001540) | 1.84741385 |
| 156 | Acute encephalopathy (HP:0006846) | 1.83854028 |
| 157 | Lethargy (HP:0001254) | 1.83740783 |
| 158 | Urinary urgency (HP:0000012) | 1.83613195 |
| 159 | Abnormality of serum amino acid levels (HP:0003112) | 1.83440357 |
| 160 | Drooling (HP:0002307) | 1.83393431 |
| 161 | Brushfield spots (HP:0001088) | 1.82235309 |
| 162 | Epistaxis (HP:0000421) | 1.81898598 |
| 163 | Sclerocornea (HP:0000647) | 1.81518688 |
| 164 | Aqueductal stenosis (HP:0002410) | 1.81497737 |
| 165 | Abnormality of the labia majora (HP:0012881) | 1.81316151 |
| 166 | Postaxial hand polydactyly (HP:0001162) | 1.81109183 |
| 167 | Recurrent abscess formation (HP:0002722) | 1.80887375 |
| 168 | Broad-based gait (HP:0002136) | 1.80531386 |
| 169 | Gaze-evoked nystagmus (HP:0000640) | 1.79933045 |
| 170 | Congenital hepatic fibrosis (HP:0002612) | 1.79800590 |
| 171 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78731298 |
| 172 | Hypothermia (HP:0002045) | 1.78394727 |
| 173 | Pancytopenia (HP:0001876) | 1.78217156 |
| 174 | Anencephaly (HP:0002323) | 1.77807258 |
| 175 | Action tremor (HP:0002345) | 1.77674137 |
| 176 | Nephronophthisis (HP:0000090) | 1.76680149 |
| 177 | Chorioretinal atrophy (HP:0000533) | 1.76436592 |
| 178 | Spastic diplegia (HP:0001264) | 1.75726688 |
| 179 | Granulocytopenia (HP:0001913) | 1.75611930 |
| 180 | Steatorrhea (HP:0002570) | 1.75237865 |
| 181 | Abnormality of methionine metabolism (HP:0010901) | 1.75065097 |
| 182 | Febrile seizures (HP:0002373) | 1.74957506 |
| 183 | Cortical dysplasia (HP:0002539) | 1.74045872 |
| 184 | Increased serum lactate (HP:0002151) | 1.73971121 |
| 185 | Impaired vibratory sensation (HP:0002495) | 1.73619652 |
| 186 | Dialeptic seizures (HP:0011146) | 1.73598115 |
| 187 | Decreased testicular size (HP:0008734) | 1.71722307 |
| 188 | Abnormality of the renal medulla (HP:0100957) | 1.70687894 |
| 189 | Hyperventilation (HP:0002883) | 1.69191009 |
| 190 | Colon cancer (HP:0003003) | 1.68270139 |
| 191 | Excessive salivation (HP:0003781) | 1.65356371 |
| 192 | Inability to walk (HP:0002540) | 1.64709626 |
| 193 | Preaxial hand polydactyly (HP:0001177) | 1.64122848 |
| 194 | Decreased circulating renin level (HP:0003351) | 1.62600444 |
| 195 | Decreased central vision (HP:0007663) | 1.61705627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 5.93404749 |
| 2 | FRK | 5.09638562 |
| 3 | STK16 | 3.69099837 |
| 4 | TRIM28 | 3.31881454 |
| 5 | WEE1 | 3.27064486 |
| 6 | BCKDK | 3.02715896 |
| 7 | CDK19 | 2.89792461 |
| 8 | MAP4K1 | 2.78059021 |
| 9 | BRSK2 | 2.43264470 |
| 10 | WNK3 | 2.31007240 |
| 11 | MST4 | 2.08643131 |
| 12 | FGFR2 | 2.08530584 |
| 13 | SCYL2 | 2.04128405 |
| 14 | EIF2AK1 | 1.97777099 |
| 15 | PBK | 1.96438317 |
| 16 | BMPR1B | 1.93692954 |
| 17 | PLK3 | 1.90867344 |
| 18 | OBSCN | 1.83074418 |
| 19 | MAP3K12 | 1.79790295 |
| 20 | ACVR1B | 1.79619898 |
| 21 | CCNB1 | 1.77922598 |
| 22 | FLT3 | 1.77320458 |
| 23 | TXK | 1.75061510 |
| 24 | LIMK1 | 1.70678010 |
| 25 | BUB1 | 1.69097333 |
| 26 | CASK | 1.65989494 |
| 27 | STK10 | 1.64535198 |
| 28 | MAP3K4 | 1.64519951 |
| 29 | KIT | 1.62819032 |
| 30 | BRSK1 | 1.59019325 |
| 31 | CAMKK1 | 1.57329166 |
| 32 | ADRBK2 | 1.56281115 |
| 33 | ZAK | 1.55455362 |
| 34 | BTK | 1.47947320 |
| 35 | MAPKAPK5 | 1.46974835 |
| 36 | PLK4 | 1.46257745 |
| 37 | SRPK1 | 1.44299476 |
| 38 | OXSR1 | 1.42417275 |
| 39 | ITK | 1.34777687 |
| 40 | ERN1 | 1.34306597 |
| 41 | TESK2 | 1.33326715 |
| 42 | NEK1 | 1.28671156 |
| 43 | PLK2 | 1.28048322 |
| 44 | SYK | 1.27596394 |
| 45 | VRK1 | 1.25242207 |
| 46 | RPS6KA4 | 1.24477172 |
| 47 | NEK9 | 1.22643764 |
| 48 | MAPK13 | 1.22381791 |
| 49 | GRK7 | 1.18518737 |
| 50 | TGFBR2 | 1.18340007 |
| 51 | TEC | 1.17036353 |
| 52 | ZAP70 | 1.16485411 |
| 53 | MAP4K2 | 1.16318710 |
| 54 | TSSK6 | 1.13368972 |
| 55 | LRRK2 | 1.12653301 |
| 56 | MAP2K7 | 1.10123107 |
| 57 | CSF1R | 1.08478497 |
| 58 | CAMKK2 | 1.07706973 |
| 59 | TYK2 | 1.02673819 |
| 60 | TNIK | 1.00582592 |
| 61 | GRK6 | 0.98805720 |
| 62 | INSRR | 0.98728781 |
| 63 | TBK1 | 0.98468570 |
| 64 | EPHA3 | 0.95652710 |
| 65 | TGFBR1 | 0.94880936 |
| 66 | MAP3K14 | 0.94731253 |
| 67 | PRKCE | 0.94275821 |
| 68 | STK38L | 0.88278957 |
| 69 | EEF2K | 0.87491903 |
| 70 | CSNK1G1 | 0.84833706 |
| 71 | LCK | 0.84752012 |
| 72 | TYRO3 | 0.80648275 |
| 73 | NTRK3 | 0.80614738 |
| 74 | AKT3 | 0.80324847 |
| 75 | LYN | 0.80003620 |
| 76 | PKN2 | 0.79945730 |
| 77 | CSNK1G2 | 0.79177681 |
| 78 | TTK | 0.77561555 |
| 79 | SIK3 | 0.75859703 |
| 80 | NLK | 0.75501148 |
| 81 | BCR | 0.75119988 |
| 82 | NEK2 | 0.73929553 |
| 83 | JAK3 | 0.73710683 |
| 84 | KDR | 0.73412512 |
| 85 | PINK1 | 0.72745344 |
| 86 | MINK1 | 0.71465366 |
| 87 | CDK8 | 0.71160829 |
| 88 | STK39 | 0.70627335 |
| 89 | PRKCG | 0.68966895 |
| 90 | CDC7 | 0.68704515 |
| 91 | MAP3K10 | 0.68534851 |
| 92 | PAK4 | 0.68514691 |
| 93 | MARK1 | 0.67946608 |
| 94 | MKNK1 | 0.67505269 |
| 95 | FGFR4 | 0.67137710 |
| 96 | ERBB3 | 0.65938800 |
| 97 | CAMK1D | 0.64273349 |
| 98 | DAPK1 | 0.64125503 |
| 99 | EPHA4 | 0.62446662 |
| 100 | DYRK3 | 0.60553248 |
| 101 | FER | 0.59389194 |
| 102 | ATR | 0.57912973 |
| 103 | PAK3 | 0.57609982 |
| 104 | CSNK1A1L | 0.54721539 |
| 105 | PRKACB | 0.52524486 |
| 106 | EIF2AK2 | 0.52145197 |
| 107 | MELK | 0.51976002 |
| 108 | CSNK1G3 | 0.51253824 |
| 109 | KSR1 | 0.51196378 |
| 110 | CAMK2A | 0.51095259 |
| 111 | IGF1R | 0.50055346 |
| 112 | STK11 | 0.49947944 |
| 113 | ATM | 0.49933976 |
| 114 | MAP3K8 | 0.48864413 |
| 115 | ADRBK1 | 0.48387652 |
| 116 | FES | 0.48270850 |
| 117 | YES1 | 0.48075405 |
| 118 | EGFR | 0.47620948 |
| 119 | MAP2K6 | 0.46709644 |
| 120 | AURKB | 0.46653176 |
| 121 | BRD4 | 0.46579549 |
| 122 | NUAK1 | 0.46368248 |
| 123 | NTRK2 | 0.45517623 |
| 124 | SGK2 | 0.45141773 |
| 125 | GRK5 | 0.45059816 |
| 126 | CDK4 | 0.44913450 |
| 127 | TAOK3 | 0.44588000 |
| 128 | GRK1 | 0.44457333 |
| 129 | MAPK4 | 0.43597226 |
| 130 | CHEK2 | 0.43197728 |
| 131 | PRKACA | 0.41571338 |
| 132 | PRKCB | 0.41447264 |
| 133 | JAK2 | 0.39679960 |
| 134 | CDK6 | 0.39244872 |
| 135 | RPS6KB2 | 0.38904389 |
| 136 | PRKG2 | 0.38483655 |
| 137 | STK4 | 0.37670449 |
| 138 | TRPM7 | 0.36802645 |
| 139 | EIF2AK3 | 0.36516437 |
| 140 | CAMK2B | 0.35312535 |
| 141 | PLK1 | 0.35130527 |
| 142 | PRKCQ | 0.34743425 |
| 143 | PHKG2 | 0.34346797 |
| 144 | PHKG1 | 0.34346797 |
| 145 | AURKA | 0.34228399 |
| 146 | MAP3K5 | 0.33662844 |
| 147 | CDK3 | 0.33539413 |
| 148 | TESK1 | 0.32390118 |
| 149 | CSNK1A1 | 0.32187626 |
| 150 | IKBKE | 0.31232197 |
| 151 | DYRK1A | 0.31044495 |
| 152 | IKBKB | 0.30792884 |
| 153 | MAP2K4 | 0.28729802 |
| 154 | PRKCH | 0.28681172 |
| 155 | CLK1 | 0.26990772 |
| 156 | HIPK2 | 0.25466487 |
| 157 | CDK7 | 0.25462348 |
| 158 | ROCK2 | 0.24467727 |
| 159 | MKNK2 | 0.24374853 |
| 160 | MAPK7 | 0.23712153 |
| 161 | NME2 | 0.23332448 |
| 162 | MAPK11 | 0.23296795 |
| 163 | ERBB4 | 0.22680538 |
| 164 | PIK3CA | 0.22573815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.39947770 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.19789872 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.06196997 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.81801922 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.74487436 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.50959778 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.43520592 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.40079762 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.33479686 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.29284865 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.25323192 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.24848572 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.19247131 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.16065401 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.04157085 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.01084274 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98988975 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94903992 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.88501330 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85118920 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.82038869 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74848425 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73955715 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73642553 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70894009 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.63186429 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61053335 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60554153 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60017696 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58391650 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.55696729 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48805723 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48264540 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.47969463 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47273012 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.45164545 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.41591468 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41578219 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.41322596 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41290802 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38189068 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37490109 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.36295427 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 1.32745998 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27291799 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26851816 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26643124 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25849962 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25320822 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.25316641 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24708061 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23301718 |
| 53 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22784359 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.20283449 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.18135880 |
| 56 | Homologous recombination_Homo sapiens_hsa03440 | 1.17526629 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17129862 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15570964 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.15436116 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15178242 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 1.14201128 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13597370 |
| 63 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.12281109 |
| 64 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12065684 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11370134 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07590615 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07409460 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05330223 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02529325 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01227406 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00706291 |
| 72 | RNA transport_Homo sapiens_hsa03013 | 0.99512027 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.99117485 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.98274959 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97453027 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95260540 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92059677 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91545629 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90944128 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90875594 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89653579 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88125827 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85624346 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85474016 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85022365 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83905394 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80541218 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78689873 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76202070 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76002278 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75407616 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75318995 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74683776 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73969433 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72364957 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.71637393 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71342164 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.69754615 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69376965 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69100633 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67509738 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.64849643 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.64306330 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64069724 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60366762 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60035692 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57993072 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57669801 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57278869 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56810250 |
| 111 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56596068 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52968691 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.52899549 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52668960 |
| 115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.52503385 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51986315 |
| 117 | Salivary secretion_Homo sapiens_hsa04970 | 0.51533261 |
| 118 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51525270 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51469293 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49584900 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49373973 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49178413 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48789943 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45664525 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.45272331 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44784605 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42199792 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.41374657 |
| 129 | Legionellosis_Homo sapiens_hsa05134 | 0.41180277 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41034725 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39333407 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38798889 |
| 133 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37872472 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37513302 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36832438 |
| 136 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36217374 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35983451 |
| 138 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35941069 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35720418 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35557970 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34481796 |
| 142 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33832194 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33822806 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33547676 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.33259730 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32738114 |
| 147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31225713 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30434085 |
| 149 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30147310 |
| 150 | Long-term depression_Homo sapiens_hsa04730 | 0.29650375 |
| 151 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29120928 |
| 152 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28356189 |
| 153 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26767596 |

